Lipocine Competitors and Similar CompaniesClear all
Lipocine's competitors and similar companies include Aptuit, BioCryst Pharmaceuticals, TiGenix and Proteros.
 Lipocine Lipocine is a specialty pharmaceutical company developing innovative pharmaceutical products for use in men’s and women’s health. |  Aptuit Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions. |  BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  TiGenix TiGenix NV is a leading European cell therapy company with an advanced clinical stage pipeline of adult stem cell programmes. | ||
Founding Date | Founding Date 1997 | Founding Date 1993 | Founding Date 1986 | Founding Date 2000 | Founding Date 2000 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Salt Lake City, US HQ Trenton, US | Locations Greenwich, US HQ Verona, IT Reinach, CH Milton, GB | Locations Durham, US HQ Hoover, US | Locations Leuven, BE HQ | Locations Planegg, DE HQ Cambridge, US |
Employees | Employees 1220% increase | Employees 761 | Employees 14040% increase | Employees 494% decrease | Employees 147 |
Valuation ($) | Valuation ($) 29.8 m | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($9.6m) (FY, 2025) | Net income N/A | Net income $263.9m (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 1.9m | Total funding raised $ 37.5m | Total funding raised $ 7m |
For sources of this data, please see the company profile
View Company Profiles
Aptuit
HQ
Greenwich, US
Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.
View companyBioCryst Pharmaceuticals
HQ
Durham, US
Employees
140↑ 40% increase
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View companyTiGenix
HQ
Leuven, BE
TiGenix NV is a leading European cell therapy company with an advanced clinical stage pipeline of adult stem cell programmes.
View company
Proteros
HQ
Planegg, DE
Proteros biostructures is a company that provides early-stage drug discovery services.
View company